Papers: 10.1007/s00259-019-04358-9
https://doi.org/10.1007/s00259-019-04358-9
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
Cited by: 49
Author(s): Sarah R. Verhoeff, Suzanne C. van Es, Eline Boon, Erik van Helden, Lindsay Angus, Sjoerd G. Elias, Sjoukje F. Oosting, Erik H.J.G. Aarntzen, Adrienne H. Brouwers, Thomas C. Kwee, Sandra Heskamp, Otto S. Hoekstra, Henk M.W. Verheul, Astrid A.M. van der Veldt, Elisabeth G.E. de Vries, Otto C. Boerman, Winette T.A. van der Graaf, W.J.G. Oyen, Carla M.L. van Herpen
Published: over 7 years ago
Software Mentions 3
Very Likely Science (100)
Very Likely Science (100)
Very Likely Science (75)